Stock ELVN ENLIVEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Enliven Therapeutics, Inc.

Equities

ELVN

US29337E1029

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
24 USD +4.17% Intraday chart for Enliven Therapeutics, Inc. -2.00% +73.41%
May. 14 Enliven Therapeutics Q1 Loss Narrows MT
Apr. 11 Enliven Therapeutics, Inc. Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mizuho Securities Initiates Enliven Therapeutics With Buy Rating, Price Target is $34
MT
Jefferies Initiates Enliven Therapeutics at Buy With $27 Price Target
MT
TD Cowen Starts Enliven Therapeutics at Outperform
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELVN Stock
  4. News Enliven Therapeutics, Inc.
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW